| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/01/2023 | 469.11% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 12/09/2022 | 469.11% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 12/08/2022 | 225.2% | Maxim Group | → $4 | Initiates Coverage On | → Buy |
What is the target price for Blue Water Vaccines (BWV)?
The latest price target for Blue Water Vaccines (NASDAQ: BWV) was reported by HC Wainwright & Co. on February 1, 2023. The analyst firm set a price target for $7.00 expecting BWV to rise to within 12 months (a possible 469.11% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Blue Water Vaccines (BWV)?
The latest analyst rating for Blue Water Vaccines (NASDAQ: BWV) was provided by HC Wainwright & Co., and Blue Water Vaccines reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Blue Water Vaccines (BWV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Blue Water Vaccines, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Blue Water Vaccines was filed on February 1, 2023 so you should expect the next rating to be made available sometime around February 1, 2024.
Is the Analyst Rating Blue Water Vaccines (BWV) correct?
While ratings are subjective and will change, the latest Blue Water Vaccines (BWV) rating was a reiterated with a price target of $0.00 to $7.00. The current price Blue Water Vaccines (BWV) is trading at is $1.23, which is within the analyst's predicted range.